Healthcare Pharmaceutical Biotech

CVS Health: Thank You! Mews at St. Mary Affordable Housing Grand Opening - Williamstown, New Jersey

July 7, 2026 8:30 AM

Last week, we proudly celebrated the Grand Opening and Building Dedication of Mews at St. Mary in Williamstown, NJ, alongside our amazing colleagues, local leaders, community organizations, development partners, and The Bishop of Camden. Mews at St. Mary is now home to 75 affordable homes for seniors, thoughtfully designed to encourage community, friendship, and support for our aging population. Developed by The Diocese of Camden and The Walters...

Read more

KIFFIK Biomedical Appoints Dr. Mark Vreeke as Chief Technology Officer

July 7, 2026 8:00 AM

KIFFIK Biomedical Inc. ("KIFFIK"), a biotechnology company advancing access to interstitial fluid (ISF) to create new visibility into human biology, today announced that Mark Vreeke, Ph.D., has joined the company as Chief Technology Officer (CTO). Dr. Vreeke brings more than three decades of experience developing and scaling biosensor and medical device technologies. He is an inventor with more than one hundred issued U.S. patents and an author...

Read more

June Monthly Letter - Strong Pipeline and Preparations for An Intensive Autumn

July 7, 2026 3:05 AM

iZafe Group (STO:IZAFE-B) - June was a month in which we continued to build on the increased activity we have seen during the spring. At the same time, the upcoming holiday period is affecting the pace of certain decisions and implementations. Our focus has therefore been on driving forward the deals and start-ups that can be closed before the holidays, while also building structure and capacity ahead of an intensive autumn. The development of...

Read more

4MAX by HeroMD Official Website Under Review: The Quad-Ingredient ED Formula for Men

July 6, 2026 8:50 PM

Title Reference Notice: The phrase "Official Website Under Review" in this article's title refers to this sponsored publishers own editorial verification process - a look at what HeroMD's official website at heromd.us/ed/4-max currently states, what's confirmed, and where the brand's own materials don't line up with each other. It does not refer to any regulatory action, legal proceeding, or government investigation. No such action is implied or...

Read more

Electronic Caregiver Expands Access to Intelligent Care Across New Mexico While Advancing the Rio Grande Health Technology and Services Corridor

July 6, 2026 6:10 PM

Electronic Caregiver, Inc., New Mexico's pioneering healthcare technology company, today announced a series of milestones that significantly expand access to intelligent care throughout the state while reinforcing New Mexico's emergence as a national center for healthcare innovation. The company has achieved New Mexico Medicaid in-network provider status, received approval under the state's Developmental Disabilities (DD) Waiver Program, and...

Read more

Nordic Named 2026 No. 1-Rated EHR Optimization, Workflow Redesign and Selective Implementation Advisory Firm for U.S. Providers by Black Book

July 6, 2026 4:15 PM

Black Book Market Research LLC today announced that Nordic Consulting ranked No. 1 overall in the 2026 Black Book benchmark of Healthcare IT Consulting & Advisory Services: USA - EHR Optimization, Workflow Redesign and Selective Implementation. The ranking reflects Black Book's Q2 2026 client-scoring cycle of 620 qualified provider-side executive respondents representing 145 provider organizations with direct exposure to implemented EHR...

Read more

Update DEA Hearing July 6: Harvard Expert Testifies State Dispensary Cannabis Does Not Meet Pharmaceutical Standards

July 6, 2026 3:03 PM

MMJ International Holdings, Inc. (MMJIH), together with MMJ BioPharma Cultivation, Inc. and MMJ BioPharma Labs, Inc., today responded to the Department of Justice's recent filing before the U.S. Court of Appeals for the District of Columbia Circuit while highlighting testimony presented Monday during the Drug Enforcement Administration's marijuana rescheduling hearing. In opposing MMJ's appellate motion for a stay pending review, DOJ argued...

Read more

The Name Long Islanders Are Seeing on the Road to the Hamptons: Dr. David Pincus of Pincus Plastic Surgery

July 6, 2026 2:05 PM

Every summer, thousands of Long Islanders and visitors make the drive east toward the Hamptons. Along the way, they pass familiar landmarks, local businesses, and iconic stretches of roadway that have become part of the experience of traveling across Long Island. This year, one name has become increasingly difficult to miss: Dr. David Pincus of Pincus Plastic Surgery. Positioned along one of the region's most heavily traveled routes, a prominent...

Read more

MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction

July 6, 2026 9:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company, today announced positive results from preclinical studies evaluating the optimized oral formulation of SKNY-1, the Company's oral drug candidate being developed for obesity and addiction-related disorders. The studies demonstrated favorable oral bioavailability together with reproducible systemic exposure and robust brain penetration, and...

Read more

CVS Health Foundation Invests $1 Million in Hartford Nonprofits Tackling Community Health Needs

July 6, 2026 9:00 AM

The CVS Health Foundation is investing $1 million in grants through its Hometown Fund to 20 organizations that are making a difference for the Greater Hartford area every day. This year, Hometown Fund grants will support local nonprofits working to increase access to health care, address food insecurity, expand availability of stable housing and increase access to critical community services across the Greater Hartford area. "We're investing in...

Read more

As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo

July 6, 2026 8:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, updates that it has continued to advance its broad-spectrum antiviral drug NV-387 towards a Phase II Clinical Trial of the NV-387 Oral Gummies formulation as a Treatment for the Current Bundibugyo Ebolavirus in the Democratic Republic of Congo (DRC). NanoViricides has already put together a team with a renowned...

Read more

BioNxt Advances GLP-1 Sublingual Semaglutide ODF Program with Next Stage of Delivery Development Underway

July 6, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce continued progress in its sublingual Semaglutide oral dissolvable film ("ODF") program, marking the next stage of development for the Company's GLP-1 delivery platform. Expanding BioNxt's Thin-Film Platform into GLP-1 Therapeutics BioNxt's Semaglutide ODF program is...

Read more

Karpa Health Launches Turnkey Nationwide Telehealth Platform as GLP-1, Peptide, and Hormone Demand Accelerates

July 3, 2026 10:45 PM

Karpa Health today announced the general availability of its turnkey telehealth platform, giving entrepreneurs, creators, gym owners, med spas, wellness brands, and clinicians the fastest way to launch high-demand health programs under their own brand. Karpa Health telehealth platform preview The announcement comes as demand for GLP-1 medications and peptide therapies continues to accelerate, while an evolving regulatory landscape is increasing...

Read more

Telos Rx GLP-1 Reviews 2026: The $49 Headline Price vs. the $129-$449 Real Monthly Cost

July 3, 2026 7:40 PM

Quick disclosure before you read further: this is a paid advertorial, and this content is promotional in nature and is intended for consumer education regarding a commercially available service, not medical advice, diagnosis, or treatment. A commission is earned if you purchase through links in this article. Product and pricing claims are attributed to the brand and are not independently endorsed. Telos Rx's compounded medications are not...

Read more

Medicure Announces CFO Change

July 3, 2026 5:00 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced that Haaris Uddin has resigned from his role as Chief Financial Officer ("CFO") of the Company, effective July 24, 2026, to pursue an opportunity in an unrelated industry. James Kinley, who was the...

Read more

Medical Care Technologies Inc. (OTC Pink:MDCE) Subsidiary Infinite Auctions Presents Kobe Bryant 2001 NBA Finals Championship Sneakers with $200,000 Buy It Now Option

July 3, 2026 10:00 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that two of the most significant Kobe Bryant game-worn sneaker lots in recent years are now available in its Infinite Auctions Summer 2026 Game Used Flash Auction at https://infiniteauctions.com/auctions, currently live and running through Saturday, July 18, 2026 at 9:00 PM EST. Both lots feature exceptional provenance, dual signatures, and ironclad photo-match authentication by...

Read more

Ascelia Pharma Provides Update on the Orviglance NDA

July 3, 2026 8:35 AM

Ascelia Pharma AB (publ) (STO:ACE), a biotechnology company focused on improving the lives of people living with rare cancer conditions, today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Company's New Drug Application (NDA) for Orviglance®. Ascelia will engage with the FDA to find an expedited path forward. The FDA has informed the Company that it is currently...

Read more

The Black Book of Reshoring by Douglas Brown Named Finalist in 2026 International Book Awards Business Category

July 3, 2026 7:00 AM

The Black Book of Reshoring: The Essential Guide to America's New Manufacturing Boom by Douglas Brown has been named a Finalist in the Business: General category of the 2026 International Book Awards, recognizing the Wiley-published title as one of the standout business books of the year. Presented by American Book Fest, the International Book Awards recognize excellence across mainstream, independent and self-published titles. Finalist...

Read more

DOJ's Marijuana Rescheduling Court Filing Sends a Dangerous Message

July 3, 2026 2:20 AM

MMJ International Holdings, Inc. (MMJIH), together with its subsidiaries MMJ BioPharma Cultivation, Inc. and MMJ BioPharma Labs, Inc. (collectively "MMJ"), today issued a sharp rebuke of the U.S. Department of Justice (DOJ) following the government's latest filing before the U.S. Court of Appeals for the District of Columbia Circuit. MMJ has been spearheading cannabinoid based clinical research for Huntington's disease and multiple sclerosis. In...

Read more

HumeCare+ Reviews 2026: Pricing, Hume Pod, GLP-1 Program Details, and What Buyers Should Verify Before Enrolling

July 2, 2026 9:45 PM

Quick disclosure: this is a paid advertorial. A commission is earned if you purchase through links here. Product claims are attributed to the brand, not independently endorsed. Compounded medications referenced below are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Official site: humecare.com. Details reflect brand materials reviewed in July 2026. Phrases like "the smarter way to lose...

Read more